Donor Lymphocyte Infusions Used to Treat Mixed Chimeric and High-Risk Patient Populations in the Relapsed and Non-Relapsed Settings after Allogeneic Transplant for Hematologic Malignancies are Associated with High 5-Year Survival if Persistent Full Donor Chimerism is Obtained or Maintained
Caldemeyer, Lauren E., Akard, Luke P., Edwards, John R., Tandra, Anand, Wagenknecht, Dawn R., Dugan, Michael J.Langue:
english
Journal:
Biology of Blood and Marrow Transplantation
DOI:
10.1016/j.bbmt.2017.07.007
Date:
July, 2017
Fichier:
PDF, 890 KB
english, 2017